Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Med Microbiol ; 55(Pt 10): 1419-1423, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17005792

RESUMEN

Currently there are 93 validated M serotypes of Streptococcus pyogenes, Lancefield group A streptococcus (GAS), and >130 emm genotypes. A marked increase in the number of non-typable GAS isolates (2 % in 2000, 4 % in 2001 and 9 % in 2002) from invasive disease cases referred to the authors' reference laboratory was noted during 2000-2002. A total of 217 (92 %) were from blood cultures, 14 (6 %) from deep abscesses and five (2 %) from aspirates. The clinical manifestations included bacteraemia, septicaemia, cellulitis, meningitis, necrotizing fasciitis and toxic-shock syndrome. In order to establish whether this increase was due to the emergence of novel types or the unavailability of M-typing sera, these isolates were subjected to emm sequencing. A total of 144 isolates (61 %) belonged to M types for which sera were no longer available; 112 (48 %) belonged to higher M types, including emm83.1 (9 %), emm94 (8 %) emm87 (6 %) and emm89 (6 %); and 32 (13 %) belonged to lower M types that were not commonly isolated in the UK, and included M25, M43, M49, M64, M73 and M74. Sixty-six (28 %) of the isolates belonged to newly designated emm types. Other isolates belonged to the novel emm types st2147, STNS1033 and st854, recently registered in the Centers for Disease Control (CDC) database by other laboratories. One novel emm type, st2161, was isolated from an injecting drug user. There were differences in the type distribution of these isolates according to geographic location. However, 90 % of emm93, one of seven predominant emm types identified amongst the collection of M non-typable (MNT) isolates, were isolated from the London region.


Asunto(s)
Antígenos Bacterianos/clasificación , Proteínas de la Membrana Bacteriana Externa/clasificación , Proteínas Portadoras/clasificación , Infecciones Estreptocócicas/microbiología , Streptococcus pyogenes/clasificación , Absceso/microbiología , Secuencia de Aminoácidos , Antígenos Bacterianos/genética , Bacteriemia/microbiología , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas Portadoras/genética , Inglaterra/epidemiología , Genes Bacterianos , Humanos , Datos de Secuencia Molecular , Análisis de Secuencia de Proteína , Serotipificación , Especificidad de la Especie , Infecciones Estreptocócicas/prevención & control , Gales/epidemiología
2.
J Med Microbiol ; 52(Pt 6): 525-526, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12748273

RESUMEN

During 2000, the UK witnessed a sudden increase in severe infections and related deaths in injecting drug users (IDUs), sparking off a UK-wide investigation. A worrying upward trend in severe group A streptococcal (GAS) infections has recently been observed in IDUs based upon isolate referrals to the PHLS Respiratory and Systemic Infection Laboratory. Most cases were young male adults who presented with skin sepsis and bacteraemia. Serotyping revealed a diverse range of M types, with higher types predominating in some geographical areas. The data suggest that GAS invasive soft-tissue infections may present in an epidemic fashion among IDUs in the absence of a common source.


Asunto(s)
Infecciones Estreptocócicas/epidemiología , Streptococcus pyogenes/aislamiento & purificación , Abuso de Sustancias por Vía Intravenosa/complicaciones , Adulto , Farmacorresistencia Bacteriana , Inglaterra/epidemiología , Humanos , Incidencia , Pruebas de Sensibilidad Microbiana , Infecciones Estreptocócicas/microbiología , Streptococcus pyogenes/efectos de los fármacos , Gales/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...